Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 7/2011

01-07-2011 | Letter to the Editor

Autoimmune hemolytic anemia and autoimmune neutropenia in a child with erythroblastopenia of childhood (TEC) caused by human herpesvirus-6 (HHV-6)

Authors: Hiroshi Yagasaki, Maiko Kato, Norio Shimizu, Hiroyuki Shichino, Motoaki Chin, Hideo Mugishima

Published in: Annals of Hematology | Issue 7/2011

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Hanada T, Koike K, Hirano C et al (1989) Childhood transient erythroblastopenia complicated by thrombocytopenia and neutropenia. Eur J Haematol 42:77–80PubMedCrossRef
2.
Rogers ZR, Bergstrom SK, Amylon M et al (1989) Reduced neutrophil counts in children with transient erythroblastopenia of childhood. J Pediatr 115:746–748PubMedCrossRef
3.
Cherrick I, Karayalcin G, Lanzkowsky P (1994) Transient erythroblastopenia of childhood. Prospective study of fifty patients. Am J Pediatr Hematol Oncol 16:320–324PubMed
4.
Sugita S, Shimizu N, Watanabe K et al (2008) Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. Br J Ophthalmol 92:928–932PubMedCrossRef
5.
Prassouli A, Papadakis V, Tsakris A et al (2005) Classic transient erythroblastopenia of childhood with human parvovirus B19 genome detection in the blood and bone marrow. J Pediatr Hematol Oncol 27:333–336PubMedCrossRef
6.
Penchansky L, Jordan JA (1997) Transient erythroblastopenia of childhood associated with human herpesvirus type 6, variant B. Am J Clin Pathol 108:127–132PubMed
7.
Skeppner G, Kreuger A, Elinder G (2002) Transient erythroblastopenia of childhood: prospective study of 10 patients with special reference to viral infections. J Pediatr Hematol Oncol 24:294–298PubMedCrossRef
8.
Liu J, Guo X, Mohandas N et al (2010) Membrane remodeling during reticulocyte maturation. Blood 115:2021–2027PubMedCrossRef
Metadata
Title
Autoimmune hemolytic anemia and autoimmune neutropenia in a child with erythroblastopenia of childhood (TEC) caused by human herpesvirus-6 (HHV-6)
Authors
Hiroshi Yagasaki
Maiko Kato
Norio Shimizu
Hiroyuki Shichino
Motoaki Chin
Hideo Mugishima
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 7/2011
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-010-1095-x

Other articles of this Issue 7/2011

Annals of Hematology 7/2011 Go to the issue

Original Article

Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells

Original Article

Chronic nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency: report of two families with novel mutations causing G6PD Bangkok and G6PD Bangkok Noi

Original Article

Additional erythrocytic and reticulocytic parameters helpful for diagnosis of hereditary spherocytosis: results of a multicentre study

Letter to the Editor

MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi)

Letter to the Editor

Acute megakaryoblastic leukemia AML FAB-M7 in a patient 15 years after kidney transplantation

Erratum

Erratum to: pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits